Novel 5-HT7 ligands as antidepressants: Automated synthesis of N-substituted-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]-arylsulfonamides

Letters in Drug Design and Discovery

Volumn 3, Issue 1, 2006, Pages 49-54

  Lattmann, Eric ^a   Merino, Isidro ^a   Dunn, Simon ^a   Parveen, Bushra ^a   Lattmann, Pornthip ^a   Billington, David C ^a   Bunprakob, Yodchai ^b   Sattayasai, Jintana ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

5 HT7 ligands; Automated synthesis; Depression; Sulfonamides

Indexed keywords

1 NAPHTHYLAMINE; 1,1 DIMETHYLHYDRAZINE; 2 AMINOBENZONITRILE; 2 AMINOPYRIDINE; 2 ANISIDINE; 3 AMINOPYRIDINE; 4 AMINOAZOBENZENE; 4 AMINOBENZONITRILE; 4 CHLOROANILINE; 4 NITROANILINE; 4 TOLUIDINE; AMINE; ANILINE; ANTIDEPRESSANT AGENT; BENZYLAMINE; BUTANEDIOL; CYANAMIDE; DODECYLAMINE; FLUOXETINE; IMIPRAMINE; METHYLAMINE; N,N DIMETHYLETHYLENEDIAMINE; PARA ANISIDINE; PHENYLETHANOLAMINE; SEROTONIN 7 RECEPTOR; SEROTONIN RECEPTOR AFFECTING AGENT; SULFONAMIDE; SULFONE DERIVATIVE; TERT BUTYLAMINE; TRIS(HYDROXYMETHYL)AMINOETHANE; UNCLASSIFIED DRUG;

ALKYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; AUTOMATION; BINDING AFFINITY; CHEMICAL PROCEDURES; CHEMICAL REACTION; COMBINATORIAL LIBRARY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DOSE RESPONSE; DRUG ACTIVITY; DRUG SYNTHESIS; IC 50; MOUSE; NONHUMAN; PRIORITY JOURNAL; REACTION ANALYSIS; RECEPTOR BINDING; SOLVENT EXTRACTION; STATISTICAL SIGNIFICANCE; SUBSTITUTION LINE; SWIMMING;

EID: 33645847857     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018006775240935     Document Type: Article

References (18)

1. Kennaway, D. J.; Rowe, S. A. and Ferguson, S. A. Brain Res., 1996, 37, 301.
2. Leysen, J. E.; Gommeren, W.; Janssen, P. M. F. and Schotte, A. Schizophrenia Res., 1996, 18, 140.
3. Gommeren, W.; Janssen, P. F. M.; Schotte, A. and Leysen, J. E. Eur. Neuropsychopharm., 1996, 6, 4.
4. Gelernter, J.; Rao, P. A.; Pauls, D. L.; Hamblin, M. W.; Sibley, D. R. and Kidd, K. K. Genomics, 1995, 26, 207.
5. Goldman, D.; Nielsen, M.; Okada, M.; Adamson, J.; Lappalainen, N.; Malhotra, U.; Pesonen, M.; Koulu, M.; Eggert, M.; Virkkunen, N.; Ozaki, M. and Linnoila, F. Biol. Psychiatr., 1996, 39, 561.
6. Forbes, I. T.; Dabbs, S.; Duckworth, D. M.; Jennings, A. J.; King, F. D.; Lovell, P. J.; Brown, A. M.; Collin, L.; Hagan, J. J.; Middlemiss, D. N.; Riley, G. J.; Thomas, D. R. and Upton, N. J. Med. Chem., 1998, 41, 655.
7. Parikh, V.; Welch, W. M. and Schmid, A. W. Bioorg. Med. Chem. Lett., 2003, 13, 269.
8. Thomson, C. G.; Beer, M. S.; Curtis, N. R.; Diggle, H. J.; Handford, E. and Kulagowski, J. J. Bioorg. Med. Chem. Lett., 2004, 14, 677.
9. Hrdina, P. D. Eur. Neuropsychopharmacology, 1996, 6, 90.
10. 3 (1 N, 3 ml, 2 times) to extract the unreacted sulfonyl chloride. A solution of NaOH (0.5 N, 2 ml) was used to extract the sulfonamides as sodium salts. The samples (water phase) were dried out afterwards. A solution of alkyl iodide E in N,N-DMF was added to every sample of sulfonamide sodium salt by the automated pipetting system. The samples were heated at 100°C for 30 h. All the N,N-DMF was lost in the process and a yellow to brown oil remained in the vials. The samples were washed with a solution of NaOH (1 N, 3 ml, 3 times) to remove the excess of sulfonamide. Then, the compounds were extracted with ethyl ether (5 ml , 5 times) and dried. As the alkyl iodide E is not soluble in ether, only the final compounds were extracted.
11. Hemedah, M.; Coupar, I. M.; Mitchelson, F. J. Bri. J. Pharmacol., 1999, 126, 179.
12. th July 2004, PCT/GB2005/002788.
13. Lattmann, E.; Sattayasai, J.; Boonprakob, J.; Lattmann, P. and Singh, H. Drug Res. / Arzneimittelforschung 2005, 55, 251.
14. Lattmann, E.; Sattayasai, J.; Billington, D. C.; Poyner, D. R.; Puapairoj, P.; Tiamkao, S.; Airarat, W.; Singh, H. and Offel, M. J. Pharm. Pharm. 2002, 54, 827.
15. 3, δ): 18.4, 21.5, 30.9, 33.6, 34.4, 40.3, 41.9, 45.6, 48.6, 51.7, 124.0, 127.3, 127.5, 128.2, 128.3, 128.4, 128.9, 133.1, 138.0, 139.1, 140.9, 168.1.
16. 3, δ): 18.4, 21.5, 30.9, 33.6, 34.4, 40.3, 41.9, 45.6, 48.6, 51.7, 124.0, 127.3, 127.5, 128.2, 128.3, 128.4, 128.9, 133.1, 138.0, 139.1, 140.9, 168.1.
17. Porsolt, R. D.; Le Pichon, M. and Jalfre, M. Nature, 1977, 266, 730.
18. Thomson, C. G.; Beer, M. S.; Curtis, N. R.; Diggle, H. J.; Handford, E. and Kulagowski, J. J. Bioorg. Med. Chem. Lett., 2004, 14, 677.